Additional file 1: of TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines

Table S1 Histopathological and follow-up information of the 64 MM patients included in the study. Table S2 Genomic amplification hotspots in MM and association test with tumor thickness, related to Figure 1. Table S3 CGH array data of NTRK1 and CDKN2A for 31 primary MM specimens (from GEO Series GSE45354). Table S4 Validation of the aCGH analysis by genomic qPCR, related to Figure 2 and Figure S1. Table S5 Copy number and mRNA expression data for NTRK1 in CCLE melanoma cell lines, related to Figure S2. Table S6 Copy number, mRNA expression, and clinical stage data for NTRK1 in TCGA melanoma samples, related to Figure S2.